Inventor · disambiguated record
Eran Blaugrund
Also filed as: BLAUGRUND ERAN
7 granted patents·38 pending applications·117 citations·filing 2003–2023
84Inventor score
Top patents by PatentIndex Score
45 records- 0193US8598203B2Treatment of Crohn's disease with laquinimodTARCIC NORA·Filed 2010·Granted Dec 3, 2013·68 cites·24 claims
- 0290US7396860B2Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosisTEVA PHARMA·Filed 2003·Granted Jul 8, 2008·43 cites·12 claims
- 0382US8946300B2Use of rasagilline for the treatment of restless legs syndromeBLAUGRUND ERAN·Filed 2007·Granted Feb 3, 2015·3 cites·29 claims
- 0479US2020093758A1Use of rasagiline for the treatment of restless legs syndromeBLAUGRUND ERAN·Filed 2019·Application pending·0 cites
- 0578US12310929B2Use of rasagiline for the treatment of restless legs syndromeBLAUGRUND ERAN·Filed 2021·Granted May 27, 2025·0 cites·18 claims
- 0676US2021251921A1Use of rasagiline for the treatment of restless legs syndromeBLAUGRUND ERAN·Filed 2021·Application pending·0 cites
- 0775US2021137852A1Use of rasagiline for the treatment of restless legs syndromeBLAUGRUND ERAN·Filed 2021·Application pending·0 cites
- 0873US2021023026A1Use of rasagiline for the treatment of restless legs syndromeBLAUGRUND ERAN·Filed 2020·Application pending·0 cites
- 0972US2020323796A1Rasagiline for the treatment of restless legs syndromeBLAUGRUND ERAN·Filed 2020·Application pending·0 cites
- 1071US2020206161A1Use of rasagiline for the treatment of restless legs syndromeBLAUGRUND ERAN·Filed 2020·Application pending·0 cites
- 1171US2019365674A1Use of rasagiline for the treatment of restless legs syndromeBLAUGRUND ERAN·Filed 2019·Application pending·0 cites
- 1270US2019262284A1Use of Rasagiline for the Treatment of Restless Legs SyndromeBLAUGRUND ERAN·Filed 2019·Application pending·0 cites
- 1369US2019142766A1Use of rasagiline for the treatment of restless legs syndromeBLAUGRUND ERAN·Filed 2018·Application pending·0 cites
- 1468US9161935B2Use of laquinimod for treating Crohn's disease patients who failed first-line anti-TNF therapyTARCIC NORA·Filed 2013·Granted Oct 20, 2015·1 cites·21 claims
- 1568US2019000780A1Use of rasagiline for the treatment of restless legs syndromeBLAUGRUND ERAN·Filed 2018·Application pending·0 cites
- 1667US2018169038A1Use of rasagiline for the treatment of restless legs syndromeBLAUGRUND ERAN·Filed 2018·Application pending·0 cites
- 1766US2015080441A1Use of rasagiline for the treatment of restless legs syndromeBLAUGRUND ERAN·Filed 2014·Application pending·0 cites
- 1866US2017360723A1Use of rasagiline for the treatment of restless legs syndromeBLAUGRUND ERAN·Filed 2017·Application pending·0 cites
- 1963US2014271532A1Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosisKREITMAN RIVKA·Filed 2014·Application pending·0 cites
- 2062US2016317471A1Use of rasagiline for the treatment of restless legs syndromeBLAUGRUND ERAN·Filed 2016·Application pending·0 cites
- 2160US8501766B2Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexateKAYE JOEL·Filed 2011·Granted Aug 6, 2013·1 cites·10 claims
- 2260US2014200243A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2014·Application pending·0 cites
- 2360US2018000812A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2017·Application pending·0 cites
- 2459US2017266180A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2017·Application pending·0 cites
- 2559US2009131535A1Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitorsTEVA PHARMA·Filed 2009·Application pending·0 cites
- 2659US2014057883A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2013·Application pending·0 cites
- 2758US2016296512A1Treatment of crohn's disease with laquinimodTEVA PHARMA·Filed 2016·Application pending·0 cites
- 2858US2017136003A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2017·Application pending·0 cites
- 2957US2017020857A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2016·Application pending·0 cites
- 3055US2012027718A1Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosisKREITMAN RIVKA·Filed 2011·Application pending·0 cites
- 3154US9308182B2Parenteral formulations of rasagilineFITZER-ATTAS CHERYL·Filed 2013·Granted Apr 12, 2016·1 cites·19 claims
- 3254US2007232691A1Use of ladostigil for the treatment of schizophreniaGOREN TAMAR·Filed 2007·Application pending·0 cites
- 3354US2024150289A1Crystalline carbazole derivativeRAZIEL THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 3453US2010167983A1Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosisTEVA PHARMA·Filed 2010·Application pending·0 cites
- 3551US2006276537A1Use of ladostigil for the treatment of multiple sclerosisGOREN TAMAR·Filed 2006·Application pending·0 cites
- 3649US2024335424A1Compositions and methods for treating lipoma painRAZIEL THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 3749US2017290822A1Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapyTARCIC NORA·Filed 2017·Application pending·0 cites
- 3848US2004010038A1Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitorsFiled 2003·Application pending·0 cites
- 3945US2024041827A1Compositions for the treatment of fat related conditions and disordersRAZIEL THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 4045US2023355584A1Compositions and methods for the treatment of lipid-related disordersRAZIEL THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 4144US2015359788A1Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapyTARCIC NORA·Filed 2015·Application pending·0 cites
- 4242US2023089484A1Compositions for the treatment of angiolipomaRAZIEL THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 4340US2022323411A1Compositions for the treatment of solid tumorsRAZIEL THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 4438US2008261894A1Combination Therapy with Glatiramer Acetate and Rasagiline for the Treatment of Multiple SclerosisKREITMAN RIVKA·Filed 2006·Application pending·0 cites
- 4532US2007244056A1Combination Therapy With Glatiramer Acetate and RiluzoleHAYARDENY LIAT·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eran Blaugrund files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →